IMMUNOVANT INC's ticker is IMVT and the CUSIP is 45258J102. A total of 149 filers reported holding IMMUNOVANT INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,454,004 | +102.8% | 63,923 | +0.2% | 0.00% | +100.0% |
| Q2 2023 | $1,210,134 | +54.3% | 63,792 | +26.1% | 0.00% | +100.0% |
| Q1 2023 | $784,372 | -14.0% | 50,572 | -1.6% | 0.00% | 0.0% |
| Q4 2022 | $911,906 | +221.1% | 51,375 | +1.0% | 0.00% | – |
| Q3 2022 | $284,000 | +43.4% | 50,863 | +0.0% | 0.00% | – |
| Q2 2022 | $198,000 | -30.0% | 50,856 | -1.1% | 0.00% | – |
| Q1 2022 | $283,000 | -39.9% | 51,445 | -7.0% | 0.00% | -100.0% |
| Q4 2021 | $471,000 | +7.5% | 55,335 | +9.8% | 0.00% | 0.0% |
| Q3 2021 | $438,000 | -19.8% | 50,396 | -2.5% | 0.00% | 0.0% |
| Q2 2021 | $546,000 | -39.8% | 51,695 | -8.6% | 0.00% | 0.0% |
| Q1 2021 | $907,000 | -65.5% | 56,540 | -0.7% | 0.00% | -75.0% |
| Q4 2020 | $2,629,000 | +41.4% | 56,915 | +7.7% | 0.00% | +33.3% |
| Q3 2020 | $1,859,000 | +164.8% | 52,832 | +83.4% | 0.00% | +200.0% |
| Q2 2020 | $702,000 | – | 28,814 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RTW INVESTMENTS, LP | 7,510,412 | $264,291,000 | 6.36% |
| Ghost Tree Capital, LLC | 525,000 | $18,475,000 | 5.34% |
| Pinz Capital Management, LP | 199,100 | $7,006,000 | 2.56% |
| ACUTA CAPITAL PARTNERS, LLC | 250,000 | $8,798,000 | 2.39% |
| BVF INC/IL | 1,198,427 | $42,173,000 | 2.30% |
| Cormorant Asset Management, LP | 1,637,951 | $57,639,000 | 2.22% |
| Vivo Capital, LLC | 1,042,460 | $36,684,000 | 2.12% |
| Parkman Healthcare Partners LLC | 150,151 | $5,284,000 | 1.40% |
| MANGROVE PARTNERS IM, LLC | 230,307 | $8,105,000 | 1.02% |
| Ikarian Capital, LLC | 321,887 | $11,328,000 | 0.82% |